Title

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.

Document Type

Journal Article

Publication Date

4-20-2017

Journal

Clinical Cancer Research : An Official Journal of the American Association for Cancer Research

DOI

10.1158/1078-0432.CCR-16-2895

Peer Reviewed

1